Role of oral rapamycin to prevent restenosis in patients with de novo lesions undergoing coronary stenting: results of the Argentina single centre study (ORAR trial)

Objective: To assess the role of oral rapamycin in the prevention of coronary restenosis in patients undergoing coronary stenting. Methods: From December 2001 through February 2003, 76 patients with 103 de novo lesions treated percutaneously with bare stents received a loading dose of oral rapamycin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rodríguez, A E, Rodríguez Alemparte, M, Vigo, C F, Fernández Pereira, C, Llauradó, C, Vetcher, D, Pocovi, A, Ambrose, J
Formato: Artigo
Idioma:Inglês
Publicado em: Copyright 2005 by Heart 2005
Assuntos:
Interventional Cardiology and Surgery
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1769178/
https://ncbi.nlm.nih.gov/pubmed/15774608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2004.050617
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados